Advertisement
There's new evidence that pre-exposure prophylaxis in the days before and after a sexual encounter with an HIV-infected partner can be effective prevention. Two new studies were presented Tuesday at the annual Conference on Retroviruses and Opportunistic Infections

CROI: Support for Pre-Exposure Prophylaxis in HIV Prevention

0
Research suggests tenofovir/emtricitabine doesn't need to be taken daily, but more study still needed
A doctor's recommendation and a patient's race may play a big role in whether or not people get an annual flu vaccine

AAAAI: Doctor’s Advice Impacts Flu Vaccination Rates

0
Recommendation, and patient race, play part in decision to get flu vaccine
Use of nonsteroidal anti-inflammatories (NSAIDs) may raise the risk for myocardial infarction (MI)

Even Short Term Use of NSAID With Anticoagulant Ill Advised

0
Findings for post-myocardial infarction patients
A centralized statewide reminder system for immunizations may be a more reliable way to increase overall vaccination rates than reminders from a doctor's office

Centralized Reminder System Could Increase Vaccination Rates

0
Centralized notification system might be more effective than doctors' office messages
People who are resistant to aspirin may be at risk for larger

AAN: Aspirin Resistance Predicts More Severe Stroke

0
What causes aspirin resistance isn't known
For patients with hepatitis C virus genotype 1 and HIV coinfection

SVR Rates Up With New Regimens for HCV and HIV Coinfection

0
Studies show high rates for all-oral, interferon-free 3D plus ribavirin regimen, ledipasvir + sofosbuvir
The use of long-acting birth control methods such as intrauterine devices or contraceptive implants jumped five-fold between 2002 and 2011

CDC: Use of Long-Acting Birth Control on Rise in U.S.

0
IUDs and implants among the safest, most effective forms of contraception
A single-nucleotide polymorphism in the promoter region of the CEP72 gene

SNP Linked to Vincristine-Related Neuropathy in ALL

0
SNP in promoter region of CEP72 gene linked to risk and severity of neuropathy in children with ALL
Farydak (panobinostat) has been approved by the U.S. Food and Drug Administration to treat multiple myeloma. Farydak inhibits the activity of histone deacetylases

FDA Approves Farydak for Multiple Myeloma

0
Drug is sanctioned for people who have received at least two prior standard therapies
Salsalate increases insulin concentrations by decreasing metabolic clearance of insulin

Salicylates Reduce Metabolic Clearance of Insulin

0
Increased insulin levels not caused by increased insulin secretion rate